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manually (by dwell times and dwell positions insertion) to the 
second CTs. DVH parameters of OARs for two image series 
were compared and analyzed. It was tried to have a minimum 
time interval between the finishing of the treatment and 
second CT scanning. Paired samples T-test (Confidence 
Interval = 95%) was done for comparing the DVH parameters 
of two planning. 
Results: Mean(%)±SD of the absolute DVH parameters 
differences for bladder, rectum and sigmoid, as the OARs of 
cervical cancer patients are reported in the following table. 
 
 
Some example of the Paired samples T-test results in term of 
Mean±SD(P-value) are: -0.24±1.63 (0.428), 0.063±0.72(0.635) 
and -0.11±0.74(0.425) for D2cc of bladder, rectum and 
sigmoid, respectively.  
Although, results of the statistical analysis showed no 
meaningful variations between DVH parameters of before and 
after treatment CTs, but the absolute differences are not 
negligible, as it can be seen from the table.  
Conclusions: Despite the fact that statistical results were not 
significant, but, the differences were large and even 
sometimes re-planning may be needed, if pre-treatment CT 
images were available just before the source loading to the 
applicators.  
It can be concluded from the results that, the same as EBRT, 
also in the brachytherapy, on line imaging, just before, or 
even during, the source loading, provides a useful insight 
about the precision of the treatment. Conventional CT scan is 
not a best choice for online imaging, because of its high 
exposure, but the other modalities like ultrasound or C-arm 
can be used an alternative, if be available in the 
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Purpose/Objective: Collecting data is expensive in terms of 
time and human resource. However data are collected 
differently and it is difficult to perform multi-center research 
based on previously stored data. The general objective of 
COBRA (COnsortium for BRachytherapy data Analysis) 
ontology is to define a specific data-set for SDC for H&N 
patients (pts) treated with brachytherapy (BT). 
Materials and Methods: ENT-COBRA is a consortium for SDC 
for H&N pts treated with BT. It is linked with H&N GEC-ESTRO 
Working Group (WG) and composed by 11 centers (10 
European and 1 Asian) from 6 countries. The ontology was 
defined by a multicenter WG, then, the proposal was 
evaluated by the consortium and by a multi-professional 
technical commission (TeCo) composed by a mathematician, 
an engineer, a doctor with experience in data storage, a 
programmer and a software (SW) expert. 
Results: 227 variables were defined. Each variable has 4 
properties: Name, Form, Type of Field and Levels. 13 Forms 
were proposed: 1) registry and history, 2) histology, 3) 
Staging, 4) Protocol, 5) Surgery, 6) Radiotherapy, 7) 
Neoadjuvant Chemotherapy (CT), 8) Concomitant CT, 9) 
Adjuvant CT, 10) BT, 11) Follow-up (repeated), 12) Outcome 
(automatically calculated based on F-up), 13) Images and 
Treatment files. Field types are: text, number, date, table, 
files. The chosen standard file formats are 'DICOM' for image 
and 'TXT files' for data treatment. All tables linked with 
variables are defined. The toxicity is stored with CTC4 scale 
and the RTOG scale (for back comparison with retrospective 
studies). RTOG scale was a forced choice because many data 
are stored using this and a direct mapping with CTC4 is not 
possible. There are 3 levels, each allowing for a specific type 
of analysis: 1) Registry level (epidemiology analysis), 2) 
Procedures level (standard oncology analysis), Research level 
(radiomics analysis). The variables of 'Registry level' are: pts 
code, Date of Birth, Gender, Ethnicity, Age, Site cancer, 
Multidisciplinary management, Institution, Histology type, 
therapy sequence, Death, Death Date, Cause of death. The 
third level includes image files. All other variables are in the 
'Procedures' level. The ontology was approved by the 
consortium and by the TeCo. The ontology has allowed to 
implement an automatic function (brokers) in COBRA SW, so 
it is not time-consuming because can take the data from 
common storage systems already in use in various centers. 
Possible update of the ontology repository are planned on 
regular bases among Consortium partners. 
Conclusions: The Ontology is a good answer to a multi-
dimensional problem that involves data collection, retrieval, 
and usability. This allows to create SW for large multi-centers 
database with the implementation of specific functions such 
as 'brokers'. The latter seem to be well received by all 
involved parties, primarily because it does not change the 
center storing technologies, procedures and habits.  
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Purpose/Objective: Aim of the COBRA project is to create a 
consortium for SDC. The long term aim is building a Decision 
Support System (DSS) to allow treatment individualisation 
and perspective validation of these prediction models. 
Materials and Methods: H&N GEC-ESTRO Working Group 
(H&N G-E WG) participated in the project defining the 
consortium agreement, the ontology (data-set) and peer-
reviewing the general 'umbrella' protocol. The repository was 
realized on a SQL platform with an authorized web-based 
access of the centres. 
Results: The project was approved by the H&N G-E WG in 
December 2012. Eleven centers (10 European and 1 Asian) 
from 6 countries signed the agreement. Then the consortium 
approved the ontology. We identified 3 levels for the data 
set: Registry (epidemiology analysis), Procedures (prediction 
models and DSS) and Research (radiomics). The consortium 
decided to divide data sharing in 2 phases: only data 
belonging to the 1st level will be stored in the 1st phase, 
while in the 2nd phase the data from the other levels. The 
COBRA-Storage System (C-SS) architecture was defined on the 
ontology basis as well on the Ethic Committee (EC) protocols. 
After some comments by an Italian EC, the C-SS was updated 
in order to improve privacy standards. The C-SS is not time-
consuming, in fact due to the use of 'brokers' it can take the 
data directly from the centres storage systems by connecting 
with SQL, Access, File Maker Pro or Excel. The system is also 
structured to perform automatic archiving directly from the 
TPS or After loading machine. We are currently in discussion 
with several companies to offer this connection. The 
architecture is based on the concept of 'on-purpose data 
projection'. It means, that a temporary, 'virtual' repository is 
created 'ad hoc' each time and a new iteration is needed for 
research purposes. The C-SS architecture is privacy 
protecting, because it will never project data that could 
identify the individual patient. At the same time, whenever a 
new iteration of a model is needed, a fresh projection is 
newly produced on which the next iteration is calculated. 
This C-SS can also benefit from the so called 'distributed 
learning' approaches, in which data never leave the collecting 
institution, while learning algorithms and proposed predictive 
models travel instead, if some consortium members choose 
not to distribute their data. 
Conclusions: Setting up a consortium appears to be a useful 
tool toward the creation of a multi-system data sharing 
architecture. The C-SS seems to be well accepted by all 
involved parties, primarily because it does not change the 
center storing technologies, procedures and habits. The 
upload of the data is planned to start in 2015 and we expect 
to begin creating predictive models as soon as the data 
collection phase is finalized  
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Purpose/Objective: There is a choice of Co-60 or Ir-192 for 
HDR Brachytherapy and recent research has suggested other 
alternative radionuclides, Co-57 and Gd-153, could be used. 
This study demonstrates the differences between these 4 
radionuclides: physically, dosimetrically and economically.  
Materials and Methods: A literature review looking at all 4 
radionuclides was performed: physical size, specific activity, 
half- life, energy and shielding requirements were compared. 
Clinically patient follow up and local planning studies 
involving 20 patients for gynaecological HDR patients were 
examined for Co-60 and Ir-192, including typical treatment 
duration, prescription point and OAR patient dosimetry. The 
monetary cost of choosing Co-60 over Ir-192 was analysed 
over a 10 year HDR equipment life. 
Results: Gd-153 while having a sufficient half-life (242 days) 
for HDR has insufficient mean photon energy at 60.9keV and 
would be more suitable for PDR or intermediate LDR. Co-57 
has a half-life of 272 days, approximately 3.5 times longer 
than Ir-192 and has lower energy gamma emissions 123keV 
without electron contamination hence it requires less source 
shielding than Ir-192 and Co-60. Its radial dose function is 
greater and more uniform than that of Ir-192 but very similar 
to Co-60 therefore producing a more uniform dose. Ir-192 and 
Co-60 are well established as the commercially available HDR 
sources, while Co-57 is not commercially available and 
requires an alpha or proton beam for production. Co-60 and 
Ir-192 have very similar physical dimensions and our planning 
studies have demonstrated small differences between the 
two radionuclides: 2.4% increase in HR-CTV (p<0.01) and 3.3% 
increase in D2cc rectum (p<0.01) when using Co-60 compared 
to Ir-192, when prescribed to ICRU Point A and with 
consistent loading patterns, these small differences may 
indeed be swamped by other larger uncertainties in 
brachytherapy. Figure 1 demonstrates the treatment duration 
with Co-60 is no longer than for an Ir-192 source for a typical 
treatment up to 4 years (typical source lifetime). The 
greatest difference is seen in the nominal costs for the 
commercially available sources and the additional physics 
support required for source changes. Co-60 is €325,000, 
€100,000 cheaper than Ir-192 over the 10 year lifetime of the 
HDR equipment. 40% additional physics support is required 
for Ir-192 source changes. 
